Oral lichen planus in Arab countries: A review

Journal of Oral Pathology and Medicine

Volumn 43, Issue 10, 2014, Pages 723-727

  Al Nasser, Lubna ^a,b   El Metwally, Ashraf ^b  

^a KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Arab; Epidemiology; Oral lichen planus; Premalignant; Prevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COSMETIC; CYCLOOXYGENASE 2; GAMMA INTERFERON; PROTEIN P21; PROTEIN P35; PROTEIN P53; SYNDECAN 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

EGYPT; HELICOBACTER INFECTION; HEPATITIS C; HUMAN; IRAQ; JORDAN; JUGLANS REGIA; LICHEN PLANUS; MALIGNANT TRANSFORMATION; PREVALENCE; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SAUDI ARABIA; CELL TRANSFORMATION; HEPATITIS, VIRAL, HUMAN; LICHEN PLANUS, ORAL; MIDDLE EAST; PATHOLOGY; RISK FACTOR;

CELL TRANSFORMATION, NEOPLASTIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LICHEN PLANUS, ORAL; MIDDLE EAST; PREVALENCE; RISK FACTORS;

EID: 84911414386     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12136     Document Type: Review

References (24)

1. Scully C, Beyli M, Ferreiro MC, et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998; 9: 86-122.
2. Ebrahimi M, Nylander K, van der Waal I. Oral lichen planus and the p53 family: what do we know? J Oral Pathol Med 2011; 40: 281-5.
3. Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A. Pathogenesis of oral lichen planus-a review. J Oral Pathol Med 2010; 39: 729-34.
4. Garcia-Pola Vallejo MJ, Martinez Diaz-Canel AI, Garcia Martin JM, Gonzalez Garcia M. Risk factors for oral soft tissue lesions in an adult Spanish population. Commun Dent Oral Epidemiol 2002;30:277-85.
5. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 164-78.
6. Salem G. Oral lichen planus among 4277 patients from Gizan, Saudi Arabia. Commun Dent Oral Epidemiol 1989; 17: 322-4.
7. Ali AA, Suresh CS. Oral lichen planus in relation to transaminase levels and hepatitis C virus. J Oral Pathol Med 2007; 36: 604-8.
8. Mani N. Preliminary report on prevalence of oral cancer and precancerous lesions among dental patients in Saudi Arabia. Commun Dent Oral Epidemiol 1985; 13: 2.
9. AlDosari A, Al-Shawaf M, Narter N, Faden A. Clinical Evaluation of 150 Saudi Patients with Lichen Planus. Saudi Dent J 1997; 9: 4.
10. Al-Mobeeriek A, AlDosari AM. Prevalence of oral lesions among Saudi dental patients. Ann Saudi Med 2009; 29: 365-8.
11. El-Rifaei AM, Fathalla SE, Al-Sheikh IH, Tinguria MB, Qadry YA. The prevalence of indices of hepatitis C and B infection, and elevated aminotransferase enzymes in patients with oral lichen planus (olp) in eastern saudi arabia. J Family Community Med 1998;5 39-43.
12. Asaad T, Samdani AJ. Association of lichen planus with hepatitis C virus infection. Ann Saudi Med 2005; 25: 243-6.
13. Al-Shawaf R, Al-Shawaf M. Hepatitis B and C virus infection and oral lichen planus: A report from Saudi Arabia. Saudi Dent J 2006; 8: 5.
14. Abdel-Latif AM, Abuel-Ela HA, El-Shourbagy SH. Increased caspase-3 and altered expression of apoptosis-associated proteins, Bcl-2 and Bax in lichen planus. Clin Exp Dermatol 2009; 34: 390-5.
15. Al-Hamdi KI. Can deram be a cause of oral lichen planus? Saudi Med J 2008; 29: 1028-30.
16. Attia EA, Abdel Fattah NS, Abdella HM. Upper gastrointestinal findings and detection of Helicobacter pylori in patients with oral lichen planus. Clin Exp Dermatol 2010;35:355-60.
17. Ghallab N, Shaker O, Gaafar S, Zayed M, Khater D. Is there a relationship between oral lichen planus and desmogliens? Egypt Dent J 2009; 55: 11.
18. Abdel Hay RM, Fawzy MM, Metwally D, et al. DNA polymorphisms and tissue cyclooxygenase-2 expression in oral lichen planus: a case-control study. J Eur Acad Dermatol Venereol 2012;26:1122-6.
19. Safadi RA, Al Jaber SZ, Hammad HM, Hamasha AA. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study. Arch Oral Biol 2010;55:454-61.
20. Zyada MM, Fikry HE. Immunohistochemical study of syndecan-1 down-regulation and the expression of P35 protein in oral lichen planus: a clinicopathologic correlation with hepatitis C infection in the Egyptian population. Ann Diagn Pathol 2010; 14: 153-61.
21. Ghallab NA, el-Wakeel N, Shaker OG. Levels of salivary IFN-gamma, TNF-alfa, and TNF receptor-2 as prognostic markers in (erosive) oral lichen planus. Mediators Inflamm 2010;2010:847632.
22. McCartan BE, Healy CM. The reported prevalence of oral lichen planus: a review and critique. J Oral Pathol Med 2008; 37: 447-53.
23. Al Robaee AA, Al Zolibani AA. Oral lichen planus and hepatitis C virus: is there real association? Acta Dermatovenerol Alp Panonica Adriat 2006;15:14-9.
24. Lodi G, Pellicano R, Carrozzo M. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis 2010; 16: 601-12.